Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Literature DB >> 3928730

Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

D Verbeelen, L Vanhaelst, M Fuss, A C Van Steirteghem.

Abstract

In normal man 1,25 (OH)2-vitamin D3 [1,25 (OH)2D] increases both basal and TRH-stimulated prolactinemia; this effect is completely reversible by the calcium antagonist nifedipine. Similarly the 1,25 (OH)2D-induced hypercalcemia is totally inhibited by nifedipine. These findings suggest that both biological effects of 1,25 (OH)2D are mediated by calcium-dependent mechanisms.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1985 PMID： 3928730 DOI： 10.1007/bf03350657

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

27 in total

1. Role of calcium in the thyrotropin-releasing hormone-stimulated release of prolactin from pituitary cells in culture.

Authors: A H Tashjian; M E Lomedico; D Maina
Journal: Biochem Biophys Res Commun Date: 1978-04-14 Impact factor: 3.575

2. Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells.

Authors: E Haug; J I Pedersen; K M Gautvik
Journal: Mol Cell Endocrinol Date: 1982-09 Impact factor: 4.102

3. Evidence that stimulation of thyrotropin and prolactin secretion by thyrotropin-releasing hormone occur via different calcium-mediated mechanisms: studies with verapamil.

Authors: E Geras; M J Rebecchi; M C Gershengorn
Journal: Endocrinology Date: 1982-03 Impact factor: 4.736

4. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.

Authors: W E Stumpf; M Sar; F A Reid; Y Tanaka; H F DeLuca
Journal: Science Date: 1979-12-07 Impact factor: 47.728

5. Calcium channel and prolactin release in rat clonal pituitary cells: effects of verapamil.

Authors: S Ozawa; N Kimura
Journal: Am J Physiol Date: 1982-07

6. Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man.

Authors: R Isaac; R Merceron; G Caillens; J P Raymond; R Ardaillou
Journal: J Clin Endocrinol Metab Date: 1980-06 Impact factor: 5.958

7. Tetracaine, propranolol and trifluoperazine inhibit thyrotropin releasing hormone-induced prolactin secretion from GH3 cells by displacing membrane calcium: further evidence that TRH acts to mobilize cellular calcium.

Authors: C Thaw; S D Wittlin; M C Gershengorn
Journal: Endocrinology Date: 1982-12 Impact factor: 4.736

8. Thyrotropin-releasing hormone stimulation of prolactin release from clonal rat pituitary cells: evidence for action independent of extracellular calcium.

Authors: M C Gershengorn; S T Hoffstein; M J Rebecchi; E Geras; B G Rubin
Journal: J Clin Invest Date: 1981-06 Impact factor: 14.808